Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae

Infection

Volumn 30, Issue 5, 2002, Pages 306-309

  Nuesch, R ^a   Rahm, G ^b   Rudin, W ^b   Steffen, I ^a   Frei, R ^a   Rufli, T ^a   Zimmerli, W ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c Medical University Clinic Liestal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD ANALYSIS; BLOOD DISEASE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DISINFECTION; FLY; FUNGUS ISOLATION; HUMAN; MAGGOT DEBRIDEMENT THERAPY; MICROBIAL CONTAMINATION; NONHUMAN; PROSPECTIVE STUDY; PROVIDENCIA STUARTII; SEPSIS; SKIN ULCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; ANIMALS; CHRONIC DISEASE; CLUSTER ANALYSIS; DEBRIDEMENT; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INCIDENCE; LARVA; MALE; MYIASIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SAMPLING STUDIES; SEPSIS; SKIN ULCER; WOUND INFECTION;

EID: 0036389565     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-3067-0     Document Type: Article

References (15)

1. Chernin E: Surgical maggots. South Med J (1986) 79: 1143-1145.
2. Baer W: The treatment of chronic osteomyelitis with the maggot (larvae of the blow fly). J Bone Joint Surg (1931) 13: 438-475
3. Payne WG, Ochs DE, Meltzer DD, Hill DP, Mannari RJ, Robson LE, Robson MC: Long-term outcome study of growth factor-treated pressure ulcers. Am J Surg (2001) 181: 81-86.
4. Veves A, Falanga V, Armstrong DG, Sabolinski ML: Graftskin, a human skin equivalent, is effective in the management of non-infected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care (2001) 24: 290-295.
5. Falabella AF, Carson P, Eaglstein WH, Falanga V:The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol (1998) 39: 737-740.
6. Steed DL, Donohoe D, Webster MW, Lindsley L: Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg (1996) 183: 61-64.
7. Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I: Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care (1998) 21: 2030-2031.
8. Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I: Maggot therapy for the treatment of intractable wounds. Int J Dermatol (1999) 38: 623-627.
9. Sherman RA, Wyle F, Vulpe M: Maggot therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med (1995) 18: 71-74.
10. Sherman RA, Tran JM, Sullivan R: Maggot therapy for venous stasis ulcers. Arch Dermatol (1996) 132: 254-256.
11. Stoddard SR, Sherman RA, Mason BE, Pelsang DJ, Sherman RM: Maggot debridement therapy. An alternative treatment for nonhealing ulcers. J Am Podiatr Med Assoc (1995) 85: 218-221.
12. Thomas S, Jones M, Shutler S, Jones S: Using larvae in modern wound management. J Wound Care (1996) 5: 60-69.
13. Thomas S, Andrews A, Jones M, Church J: Maggots are useful in treating infected or necrotic wounds. BMJ (1999) 318: 807-808.
14. Mumcuoglu KY, Miller J, Mumcuoglu M, Friger M, Tarshis M: Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol (2001) 38: 161-166.
15. Thomas S, Andrews AM, Hay NP, Bourgoise S: The antimicrobial activity of maggot secretions: results of a preliminary study. J Tissue Viability (1999) 9: 127-132.